跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 53,470 条关于
“Tumor Lysis Syndrome”
全部
53,470
临床试验
43,289
药物
784
机构
77
资讯
9,320
去年
Phase IIb/III Trial Assesses Tumor Lysis Syndrome Risk with Venetoclax Combinations in CLL
去年
Sonrotoclax Plus Zanubrutinib Shows Promise in Relapsed/Refractory Mantle Cell Lymphoma with 78% Response Rate
去年
Survey Reveals Challenges in Venetoclax Adoption for CLL Treatment in Community Settings
2年前
CLL Patients Prioritize PFS Benefits in Treatment Choices, Survey Reveals
去年
Fixed-Duration Venetoclax Regimen Reduces Long-Term Costs in CLL Treatment
去年
Lomond Therapeutics' Lonitoclax Shows Promising Safety Profile in Phase 1 Trial
2年前
Ascentage Pharma's Lisaftoclax Receives FDA Clearance for Global Phase III Trial in CLL/SLL
5年前
Acalabrutinib, Venetoclax, and Obinutuzumab Triplet Shows High Efficacy in CLL
2年前
Managing Toxicities in CLL Treatment: Expert Insights on BCL2 and BTK Inhibitor Selection
9个月前
Lisaftoclax Demonstrates 62.5% Response Rate in BTK-Refractory CLL/SLL Patients
第 1 页,共 932 页
上一页
下一页